Alzheimers
Alzheimer’s disease is characterized by progressive loss of memory and cognitive performance leading eventually to dementia. Patients have decreased cognition; loss of attention, perception, progressive memory loss, poor attention span, lack of emotional control, inappropriate sexual behavior, poor judgment and reasoning, hallucinations, delusions; failure to recognize close friends and family members and gradual deterioration of intellect.
Neuronal and synapse loss may occur throughout the brain involving the basal forebrain cholingergic system, amygdale, hippocampus and several cortical areas. Current therapy is treatment with acetylcholinesterase inhibitors to enhance cholinergic function which gives only partial and temporary alleviation of the symptoms.
The discovery of stem cells has given rise to the hope that a more specific form of treatment could be offered for Alzheimer’s. Although there are niches and reservoirs of stem cells in the brain the numbers are not enough to restore normal neurological function.
There have been previous attempts to do basal forebrain grafts of fibroblasts that produce nerve growth factor to counteract cholinergic neuron death, stimulate brain cell function and attempt to improve memory function.
Now new treatment is available from StemCellRegenMed.
-
Neurogenesis- stimulation of niches of the patient’s own stem cells in the brain with oral and injectable agents.
-
Autologous stem cells from patient’s own peripheral blood given intravenously.
-
Neuron stem cells extracted from umbilical cord blood mixed with brain neuropeptide, neurotrophins, nerve cell factor and vascular endothelial growth factor given intravenously with an agent to penetrate the blood brain barrier or given intrathecally into the spinal canal and central nervous system. Umbilical cord stem cells are pluripotent and have the ability in culture to be transformed into progenitor cells of many organs. When umbilical cord blood is placed into culture with nerve growth factor and brain neurotropic factor brain stem cell precursors develop.
-
Post treatment neurogenesis with oral and injectable agents to stimulate niches of stem cells in the brain and the exogenous neuron stem cells derived from umbilical cord blood and nerve cell growth factors administered into the central nervous system.
The sadness of seeing a bright energetic individual slowly progress into the depths of progressive brain deterioration is a devastating situation affecting the patient and entire family. Families should consider and discuss the above treatments with their neurologist and with our physicians at StemCellRegenMed.
Medical Disclaimer: Treatments discussed on this website are experimental and have not been approved by the FDA. No guarantees are made regarding the results of these treatments. Prospective patients are advised to discuss the use of a Stem Cell treatment for their disease with their physician.
